| Financial Year |
March 31 2023 |
| Monetary Funds |
559,021,142.23 |
| Held-for-trading Financial Assets |
160,000,000.00 |
| Notes Receivable |
54,392,208.43 |
| Accounts Receivable |
840,249,739.20 |
| Advances to Suppliers |
19,511,796.91 |
| Other Receivables |
83,960,472.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
854,614,200.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,752,908.95 |
| Total Current Assets |
2,936,460,502.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,376,111,948.50 |
| Under-construction Projects |
156,650,086.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
127,998,483.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
47,449,436.46 |
| Deferred Income Tax Assets |
55,503,872.06 |
| Other Non-Current Assets |
53,469,170.72 |
| Sub-Total of Non-Current Assets |
1,856,800,316.52 |
| Total Assets |
4,793,260,819.46 |
| Short-Term Loans |
588,180,628.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
307,747,677.04 |
| Accounts Payable |
1,123,968,943.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,907,254.87 |
| Taxes Payable |
23,427,106.91 |
| Interest Payable |
-- |
| Dividend Payable |
1,780,802.42 |
| Other payables |
3,474,038.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,611,181.43 |
| Other Current Liabilities |
35,607,209.00 |
| Sub-Total of Current Liabilities |
2,208,216,817.33 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
93,296,464.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,298,584.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
279,211,095.77 |
| Total Liabilities |
2,487,427,913.10 |
| Paid-In Capital(Or Share Stock) |
400,010,000.00 |
| Capital Surplus |
1,031,920,794.11 |
| Surplus Reserve |
20,078,068.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
850,216,796.71 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,305,832,906.36 |
| Owner's Equity（Stockholder's Equity） |
2,305,832,906.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,793,260,819.46 |
